Inflammation of the PERICARDIUM from various origins, such as infection, neoplasm, autoimmune process, injuries, or drug-induced. Pericarditis usually leads to PERICARDIAL EFFUSION, or CONSTRICTIVE PERICARDITIS.
Inflammation of the PERICARDIUM that is characterized by the fibrous scarring and adhesion of both serous layers, the VISCERAL PERICARDIUM and the PARIETAL PERICARDIUM leading to the loss of pericardial cavity. The thickened pericardium severely restricts cardiac filling. Clinical signs include FATIGUE, muscle wasting, and WEIGHT LOSS.
INFLAMMATION of the sac surrounding the heart (PERICARDIUM) due to MYCOBACTERIUM TUBERCULOSIS infection. Pericarditis can lead to swelling (PERICARDIAL EFFUSION), compression of the heart (CARDIAC TAMPONADE), and preventing normal beating of the heart.
Surgical excision (total or partial) of a portion of the pericardium. Pericardiotomy refers to incision of the pericardium.
Fluid accumulation within the PERICARDIUM. Serous effusions are associated with pericardial diseases. Hemopericardium is associated with trauma. Lipid-containing effusion (chylopericardium) results from leakage of THORACIC DUCT. Severe cases can lead to CARDIAC TAMPONADE.
Compression of the heart by accumulated fluid (PERICARDIAL EFFUSION) or blood (HEMOPERICARDIUM) in the PERICARDIUM surrounding the heart. The affected cardiac functions and CARDIAC OUTPUT can range from minimal to total hemodynamic collapse.
A form of CARDIAC MUSCLE disease in which the ventricular walls are excessively rigid, impeding ventricular filling. It is marked by reduced diastolic volume of either or both ventricles but normal or nearly normal systolic function. It may be idiopathic or associated with other diseases (ENDOMYOCARDIAL FIBROSIS or AMYLOIDOSIS) causing interstitial fibrosis.
Puncture and aspiration of fluid from the PERICARDIUM.
A conical fibro-serous sac surrounding the HEART and the roots of the great vessels (AORTA; VENAE CAVAE; PULMONARY ARTERY). Pericardium consists of two sacs: the outer fibrous pericardium and the inner serous pericardium. The latter consists of an outer parietal layer facing the fibrous pericardium, and an inner visceral layer (epicardium) resting next to the heart, and a pericardial cavity between these two layers.
Pathological conditions of the CARDIOVASCULAR SYSTEM caused by infection of MYCOBACTERIUM TUBERCULOSIS. Tuberculosis involvement may include the HEART; the BLOOD VESSELS; or the PERICARDIUM.
A pathologic process consisting in the formation of pus.
Pathological conditions of the CARDIOVASCULAR SYSTEM caused by infections.
An acute, febrile, infectious disease generally occurring in epidemics. It is usually caused by coxsackieviruses B and sometimes by coxsackieviruses A; echoviruses; or other enteroviruses.
Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
The aglycone constituents of CARDIAC GLYCOSIDES. The ring structure is basically a cyclopentanoperhydrophenanthrene nucleus attached to a lactone ring at the C-17 position.

Recurrent pericardial effusion: the value of polymerase chain reaction in the diagnosis of tuberculosis. (1/56)

A 23 year old army man presented with progressive dyspnoea and was found to have a massive pericardial effusion. Despite extensive investigations the cause remained elusive, until samples were sent for polymerase chain reaction (PCR). This case was unusual for several reasons and is a reminder of the atypical way in which tuberculosis infection can present and how a high index of suspicion should be maintained. It shows the importance of molecular biological advances in providing simple and rapid methods for arriving at the correct diagnosis, by way of nucleic acid probes and polymerase chain reaction.  (+info)

Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. (2/56)

OBJECTIVE: To determine the effect of adjunctive prednisolone on morbidity, pericardial fluid resolution, and mortality in HIV seropositive patients with effusive tuberculous pericarditis. DESIGN: Double blind randomised placebo controlled trial. SETTING: Two medical school affiliated referral hospitals in Harare, Zimbabwe. PATIENTS: 58 HIV seropositive patients aged 18-55 years with tuberculous pericarditis. INTERVENTIONS: All patients received standard short course antituberculous chemotherapy and were randomly assigned to receive prednisolone or placebo for six weeks. MAIN OUTCOME MEASURES: Clinical improvement, echocardiographic and radiologic pericardial fluid resolution, and death. RESULTS: 29 patients were assigned to prednisolone and 29 to placebo. After 18 months of follow up there were five deaths in the prednisolone treated group and 10 deaths in the placebo group. Mortality was significantly lower in the prednisolone group (log rank chi(2) = 8. 19, df = 1, p = 0.004). Resolution of raised jugular venous pressure (p = 0.017), hepatomegaly (p = 0.007), and ascites (p = 0.015), and improvement in physical activity (p = 0.02), were significantly more rapid in the prednisolone treated patients. However, there was no difference in the rate of radiologic and echocardiographic resolution of pericardial effusion. CONCLUSIONS: Adjunctive prednisolone for effusive tuberculous pericarditis produced a pronounced reduction in mortality. It is suggested prednisolone should be added to standard short course chemotherapy to treat HIV related effusive tuberculous pericarditis.  (+info)

Management of pericardial effusion by drainage: a survey of 10 years' experience in a city centre general hospital serving a multiracial population. (3/56)

The aim of the study was to determine the aetiology of large and symptomatic pericardial effusions and to review the management and subsequent outcome. A survey was done on a consecutive cases of patients who had undergone percutaneous pericardiocentesis over a 10 year period in a city centre general hospital serving a multiethnic catchment population. In all, 46 patients (24 male, 22 female; age range 16 to 90 years, mean 54 years) underwent a total of 51 pericardial drainage procedures (or attempted pericardiocentesis) between 1989 and 1998. Malignancy (44%), tuberculosis (26%), idiopathic (11%), and post-cardiac surgery (9%) were the most common causes of pericardial effusion. The most common presenting symptoms were breathlessness (90%), chest pain (74%), cough (70%), abdominal pain (61%) (presumed to be related to hepatic congestion), and unexplained fever (28%). In the 12 cases of tuberculous pericarditis, nine occurred in patients of Indo-Asian origin, and three in patients of Afro-Caribbean origin. Fever, night sweats, and weight loss were common among these patients, occurring in over 80% of cases of tuberculous pericarditis. Pulsus paradoxus was the most specific sign (100%) for the presence of echocardiographic features of tamponade, with strongest positive predictive value (100%). Although malignancy remains the most common cause in developed countries, tuberculous disease should be considered in patients from areas where tuberculosis is endemic. Percutaneous pericardiocentesis remains an effective measure for the immediate relief of symptoms in patients with cardiac tamponade, although its diagnostic yield in tuberculous pericarditis is relatively low.  (+info)

Tuberculous pericarditis: optimal diagnosis and management. (4/56)

Pericarditis is a rare manifestation of tuberculous disease. The appropriate diagnostic workup and optimal therapeutic management are not well defined. We present 10 new cases of tuberculous pericarditis and review the relevant literature. The specific topics addressed are (1) the importance of tissue for diagnosis, (2) the optimal surgical management, (3) the role of corticosteroids, and (4) the impact of human immunodeficiency virus (HIV) on the management of this disease. The cases and the literature suggest that the optimal management includes an open pericardial window with biopsy, both for diagnosis and to prevent reaccumulation of fluid. Corticosteroids probably offer some benefit in preventing fluid reaccumulation as well. The data are inconclusive regarding whether open drainage or corticosteroid use prevents progression to constrictive pericarditis. No studies have addressed these issues specifically in HIV-positive patients, but the 3 HIV-positive patients in our series had an excellent response to drainage and antituberculous therapy.  (+info)

Clinical characteristics of constrictive pericarditis diagnosed by echo-Doppler technique in Korea. (5/56)

A retrospective analysis of clinical data of 71 patients with constrictive pericarditis (CP) diagnosed by echo-Doppler technique (mean age, 49+/-17) was done. In 27 patients (38%), the etiology was unknown, and the three most frequent identifiable causes were tuberculosis (23/71, 32%), cardiac surgery (8/71, 11%), and mediastinal irradiation (6/71, 9%). Pericardiectomy was performed in 35 patients (49%) with a surgical mortality of 6% (2/35), and 11 patients (15%, 11/ 71) showed complete resolution of constrictive physiology with medical treatment. Patients with transient CP were characterized by absence of pericardial calcification, shorter symptom duration, and higher incidence of fever, weight loss, and tuberculosis. The 5-yr survival rates of patients with transient CP and those undergoing pericardiectomy were 100% and 85+/-6%, respectively, which were significantly higher than that of patients without undergoing pericardiectomy (33+/-17%, p=0.0083). Mediastinal irradiation, higher functional class, low voltage in ECG, low serum albumin, and old age were the independent variables associated with a higher mortality. Tuberculosis is still the most important etiology of CP in Korea, and not infrequently, it may cause transient CP. Early diagnosis and decision-making using follow-up echocardiography are crucial to improve the prognosis of patients with CP.  (+info)

Constrictive tuberculous pericarditis: case report and review of the literature. (6/56)

Constrictive pericarditis is a rare disease characterized by the encasement of the heart by a rigid, non-pliable pericardium, with impaired diastolic filling of the ventricles. Its etiology is often unclear (42%), but is frequently associated with viral infection and tuberculosis, especially in developing countries. In this article the authors present the case report of a 28 year-old black woman, born and resident in Angola, with a history of tuberculosis, admitted to our hospital with global heart failure. After investigation a diagnosis of constrictive tuberculous pericarditis was established and the patient underwent pericardiectomy. Clinical features and radiologic, electrocardiographic, echocardiographic, computed tomography, nuclear magnetic resonance imaging and hemodynamic findings are discussed. This case illustrates the importance of early pericardiotomy before the appearance of pericardiectomy before end-stage pericardial fibrosis and subsequent increased possibility of an adverse postoperative outcome.  (+info)

A case of tuberculous pericardial effusion. (7/56)

We report a case of an 80-year-old caucasian female in the UK who presented with weight loss and was found to have a pericardial effusion. There was neither previous exposure to tuberculosis nor any suggestion of immunosuppression. Repeated analysis of pericardial fluid established a tuberculous origin. Search of medical literature did not reveal any similar cases in the elderly in the UK.  (+info)

Adjuvant corticosteroids for tuberculous pericarditis: promising, but not proven. (8/56)

BACKGROUND: There is controversy regarding the effectiveness of corticosteroids in tuberculous pericarditis, particularly in patients who are immunocompromised by HIV. AIM: To determine the effectiveness of adjuvant corticosteroids in tuberculous pericarditis. DESIGN: Systematic review of randomized controlled trials. METHODS: We searched the Cochrane Infectious Diseases Group trials register (June 2002), the Cochrane Controlled Trials Register (Issue 2, 2002), MEDLINE (January 1966 to March 2003), EMBASE (1980 to May 2002), and the reference lists of existing reviews, for randomized and quasi-randomized controlled trials of adjuvant corticosteroids in the treatment of suspected tuberculous pericarditis. We also contacted organizations and individuals working in the field. Two reviewers independently assessed trial quality and extracted data. We used meta-analysis with a fixed effects model to calculate the summary statistics, provided there was no statistically significant heterogeneity, and expressed results as relative risk. RESULTS: Four trials with a total of 469 participants met our criteria. Three (total n = 411) tested adjuvant steroids in participants with suspected tuberculous pericarditis in the pre-HIV era. Fewer participants died in the intervention group, but the potentially large reduction in mortality was not statistically significant (relative risk RR 0.65, 95%CI 0.36-1.16, n = 350; p = 0.14). One trial with 58 patients that enrolled HIV-positive individuals also showed a promising but non-significant trend on mortality (RR 0.50, 95%CI 0.19-1.28; p = 0.15). There was no significant beneficial effect of steroids on re-accumulation of pericardial effusion or progression to constrictive pericarditis. Patients with pericardial effusion were significantly more likely to be alive with no functional impairment at 2 years following treatment. However, the effect was not sustained in a sensitivity analysis that included patients who were lost to follow-up. DISCUSSION: Steroids could have large beneficial effects on mortality and morbidity in tuberculous pericarditis, but published trials are too small to be conclusive. Large placebo-controlled trials are required, and should include sufficient numbers of HIV-positive and HIV-negative participants, and an adequate adjuvant steroid dose.  (+info)

Pericarditis is a medical condition characterized by inflammation of the pericardium, which is the thin sac-like membrane that surrounds the heart and contains serous fluid to reduce friction during heartbeats. The inflammation can cause symptoms such as chest pain, shortness of breath, and sometimes fever.

The pericardium has two layers: the visceral pericardium, which is tightly adhered to the heart's surface, and the parietal pericardium, which lines the inner surface of the chest cavity. Normally, there is a small amount of fluid between these two layers, allowing for smooth movement of the heart within the chest cavity.

In pericarditis, the inflammation causes the pericardial layers to become irritated and swollen, leading to an accumulation of excess fluid in the pericardial space. This can result in a condition called pericardial effusion, which can further complicate the situation by putting pressure on the heart and impairing its function.

Pericarditis may be caused by various factors, including viral or bacterial infections, autoimmune disorders, heart attacks, trauma, or cancer. Treatment typically involves addressing the underlying cause, managing symptoms, and reducing inflammation with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, or corticosteroids. In severe cases, pericardiocentesis (removal of excess fluid from the pericardial space) or surgical intervention may be necessary.

Constrictive pericarditis is a medical condition characterized by the inflammation and thickening of the pericardium, which is the sac-like membrane that surrounds the heart. This inflammation leads to scarring and thickening of the pericardium, causing it to become stiff and inflexible. As a result, the heart's ability to fill with blood between beats is restricted, leading to symptoms such as shortness of breath, fatigue, and fluid retention.

In contrastive pericarditis, the thickened and scarred pericardium restricts the normal movement of the heart within the chest cavity, leading to a characteristic pattern of hemodynamic abnormalities. These include equalization of diastolic pressures in all cardiac chambers, increased systemic venous pressure, and decreased cardiac output.

The most common causes of constrictive pericarditis include prior infection, radiation therapy, autoimmune disorders, and previous heart surgery. Diagnosis typically involves a combination of medical history, physical examination, imaging studies such as echocardiography or MRI, and sometimes invasive testing such as cardiac catheterization. Treatment may involve medications to manage symptoms and reduce inflammation, as well as surgical removal of the pericardium (pericardiectomy) in severe cases.

Tuberculous pericarditis is a specific form of pericarditis (inflammation of the pericardium, the thin sac-like membrane that surrounds the heart) that is caused by the bacterial infection of Mycobacterium tuberculosis. This type of pericarditis is more common in areas where tuberculosis is prevalent and can lead to serious complications if not diagnosed and treated promptly.

In tuberculous pericarditis, the bacteria typically spread from the lungs (the most common site of TB infection) or other infected organs through the bloodstream to the pericardium. The infection causes an inflammatory response, leading to the accumulation of fluid in the pericardial space (pericardial effusion), which can put pressure on the heart and impair its function. In some cases, the inflammation may lead to the formation of scar tissue, causing the pericardium to thicken and constrict, a condition known as constrictive pericarditis.

Symptoms of tuberculous pericarditis can include chest pain, cough, fever, fatigue, weight loss, and difficulty breathing. Diagnosis typically involves a combination of medical history, physical examination, imaging tests (such as echocardiography, CT scan, or MRI), and laboratory tests (including analysis of the pericardial fluid). Treatment usually consists of a long course of antibiotics specific to TB, along with anti-inflammatory medications and close monitoring for potential complications.

Pericardiectomy is a surgical procedure that involves the removal of all or part of the pericardium, which is the sac-like membrane surrounding the heart. This surgery is typically performed to treat chronic or recurrent pericarditis, constrictive pericarditis, or pericardial effusions that do not respond to other treatments. Pericardiectomy can help reduce symptoms such as chest pain, shortness of breath, and fluid buildup around the heart, improving the patient's quality of life and overall prognosis.

Pericardial effusion is an abnormal accumulation of fluid in the pericardial space, which is the potential space between the two layers of the pericardium - the fibrous and serous layers. The pericardium is a sac that surrounds the heart to provide protection and lubrication for the heart's movement during each heartbeat. Normally, there is only a small amount of fluid (5-15 mL) in this space to ensure smooth motion of the heart. However, when an excessive amount of fluid accumulates, it can cause increased pressure on the heart, leading to various complications such as decreased cardiac output and even cardiac tamponade, a life-threatening condition that requires immediate medical attention.

Pericardial effusion may result from several causes, including infections (viral, bacterial, or fungal), inflammatory conditions (such as rheumatoid arthritis, lupus, or cancer), trauma, heart surgery, kidney failure, or iatrogenic causes. The symptoms of pericardial effusion can vary depending on the rate and amount of fluid accumulation. Slowly developing effusions may not cause any symptoms, while rapid accumulations can lead to chest pain, shortness of breath, cough, palpitations, or even hypotension (low blood pressure). Diagnosis is usually confirmed through imaging techniques such as echocardiography, CT scan, or MRI. Treatment depends on the underlying cause and severity of the effusion, ranging from close monitoring to drainage procedures or medications to address the root cause.

Cardiac tamponade is a serious medical condition that occurs when there is excessive fluid or blood accumulation in the pericardial sac, which surrounds the heart. This accumulation puts pressure on the heart, preventing it from filling properly and reducing its ability to pump blood effectively. As a result, cardiac output decreases, leading to symptoms such as low blood pressure, shortness of breath, chest pain, and a rapid pulse. If left untreated, cardiac tamponade can be life-threatening, requiring emergency medical intervention to drain the fluid and relieve the pressure on the heart.

Restrictive cardiomyopathy (RCM) is a type of heart muscle disorder characterized by impaired relaxation and filling of the lower chambers of the heart (the ventricles), leading to reduced pump function. This is caused by stiffening or rigidity of the heart muscle, often due to fibrosis or scarring. The stiffness prevents the ventricles from filling properly with blood during the diastolic phase, which can result in symptoms such as shortness of breath, fatigue, and fluid retention.

RCM is a less common form of cardiomyopathy compared to dilated or hypertrophic cardiomyopathies. It can be idiopathic (no known cause) or secondary to other conditions like amyloidosis, sarcoidosis, or storage diseases. Diagnosis typically involves a combination of medical history, physical examination, echocardiography, and sometimes cardiac MRI or biopsy. Treatment is focused on managing symptoms and addressing underlying causes when possible.

Pericardiocentesis is a medical procedure where a needle or a catheter is inserted into the pericardial sac, the thin fluid-filled space surrounding the heart, to remove excess fluids or air that has accumulated. This buildup can put pressure on the heart and impede its function, leading to various cardiac symptoms such as chest pain, shortness of breath, and palpitations. The procedure is often guided by echocardiography or fluoroscopy to ensure proper placement and minimize risks. Pericardiocentesis may be performed as an emergency treatment or a scheduled intervention, depending on the patient's condition.

The pericardium is the double-walled sac that surrounds the heart. It has an outer fibrous layer and an inner serous layer, which further divides into two parts: the parietal layer lining the fibrous pericardium and the visceral layer (epicardium) closely adhering to the heart surface.

The space between these two layers is filled with a small amount of lubricating serous fluid, allowing for smooth movement of the heart within the pericardial cavity. The pericardium provides protection, support, and helps maintain the heart's normal position within the chest while reducing friction during heart contractions.

"Cardiovascular Tuberculosis" refers to a form of tuberculosis (TB) where the bacteria (Mycobacterium tuberculosis) infects the heart or the blood vessels. This is a less common manifestation of TB, but it can have serious consequences if left untreated.

In cardiovascular TB, the bacteria can cause inflammation and damage to the heart muscle (myocarditis), the sac surrounding the heart (pericarditis), or the coronary arteries that supply blood to the heart muscle. This can lead to symptoms such as chest pain, shortness of breath, coughing, fatigue, and fever. In severe cases, it can cause heart failure or life-threatening arrhythmias.

Cardiovascular TB is usually treated with a combination of antibiotics that are effective against the TB bacteria. The treatment may last for several months to ensure that all the bacteria have been eliminated. In some cases, surgery may be necessary to repair or replace damaged heart valves or vessels. Early diagnosis and treatment can help prevent serious complications and improve outcomes in patients with cardiovascular TB.

Suppuration is the process of forming or discharging pus. It is a condition that results from infection, tissue death (necrosis), or injury, where white blood cells (leukocytes) accumulate to combat the infection and subsequently die, forming pus. The pus consists of dead leukocytes, dead tissue, debris, and microbes (bacteria, fungi, or protozoa). Suppuration can occur in various body parts such as the lungs (empyema), brain (abscess), or skin (carbuncle, furuncle). Treatment typically involves draining the pus and administering appropriate antibiotics to eliminate the infection.

Cardiovascular infections, also known as infective endocarditis, are infections that affect the inner layer of the heart, including the heart valves. These infections are usually caused by bacteria, but they can also be caused by fungi or other microorganisms. They can occur when bacteria or other germs enter the bloodstream and then settle in the heart.

There are several types of cardiovascular infections, including:

* Native Valve Endocarditis: This occurs when an infection affects the heart valves that are present at birth.
* Prosthetic Valve Endocarditis: This occurs when an infection affects an artificial heart valve.
* Intracardiac Device-Related Infections: These infections can occur in people who have devices such as pacemakers or implantable defibrillators.
* Infectious Myocarditis: This is an inflammation of the heart muscle caused by an infection.

Symptoms of cardiovascular infections may include fever, chills, fatigue, shortness of breath, chest pain, and a new or changing heart murmur. Treatment typically involves several weeks of antibiotics, and in some cases, surgery may be necessary to remove the infected tissue. Prevention measures include good oral hygiene, prompt treatment of skin infections, and prophylactic antibiotics for certain high-risk individuals undergoing dental or surgical procedures.

Epidemic pleurodynia, also known as Bornholm disease or devils' grip, is a self-limiting viral illness characterized by sudden onset of severe, stabbing chest or upper abdominal pain. It is caused most commonly by an enterovirus, often Coxsackie A or B.

The hallmark of epidemic pleurodynia is the pleuritic nature of the pain, which is aggravated by deep breathing, coughing, or movement. The muscle spasms can be so intense that they cause the patient to assume a fetal position in order to minimize the discomfort. Other symptoms may include fever, headache, nausea, vomiting, and generalized weakness.

The term "epidemic" refers to the fact that this disease tends to occur in outbreaks, particularly during the summer and fall months. However, sporadic cases can also occur throughout the year. The illness typically lasts for 5-10 days but may rarely persist for several weeks.

Treatment is generally supportive and includes rest, hydration, and analgesics for pain relief. Antiviral medications are not usually recommended, as they have not been shown to significantly affect the course of the illness.

Myocarditis is an inflammation of the myocardium, which is the middle layer of the heart wall. The myocardium is composed of cardiac muscle cells and is responsible for the heart's pumping function. Myocarditis can be caused by various infectious and non-infectious agents, including viruses, bacteria, fungi, parasites, autoimmune diseases, toxins, and drugs.

In myocarditis, the inflammation can damage the cardiac muscle cells, leading to decreased heart function, arrhythmias (irregular heart rhythms), and in severe cases, heart failure or even sudden death. Symptoms of myocarditis may include chest pain, shortness of breath, fatigue, palpitations, and swelling in the legs, ankles, or abdomen.

The diagnosis of myocarditis is often based on a combination of clinical presentation, laboratory tests, electrocardiogram (ECG), echocardiography, cardiac magnetic resonance imaging (MRI), and endomyocardial biopsy. Treatment depends on the underlying cause and severity of the disease and may include medications to support heart function, reduce inflammation, control arrhythmias, and prevent further damage to the heart muscle. In some cases, hospitalization and intensive care may be necessary.

Cardanolides are a type of steroid compound that are found in certain plants, particularly in the family Apocynaceae. These compounds have a characteristic structure that includes a five-membered lactone ring attached to a steroid nucleus, and they are known for their ability to inhibit the sodium-potassium pump (Na+/K+-ATPase) in animal cells. This property makes cardanolides toxic to many organisms, including humans, and they have been used as heart poisons and insecticides.

One of the most well-known cardanolides is ouabain, which is found in the seeds of several African plants and has been used traditionally as a medicine for various purposes, including as a heart stimulant and a poison for hunting. Other examples of cardanolides include digoxin and digitoxin, which are derived from the foxglove plant (Digitalis purpurea) and are used in modern medicine to treat heart failure and atrial arrhythmias.

It's worth noting that while cardanolides have important medical uses, they can also be highly toxic if ingested or otherwise introduced into the body in large amounts. Therefore, it's essential to use these compounds only under the supervision of a qualified healthcare professional.

... is a form of pericarditis. Pericarditis caused by tuberculosis is difficult to diagnose, because ... The Tygerberg scoring system helps the clinician to decide whether pericarditis is due to tuberculosis or whether it is due to ...
his research interests included rheumatic fever, tuberculous pericarditis and cardiomyopathy. He was a member of the Academy of ... Bongani M Mayosi; Lesley J Burgess; Anton F Doubell (1 December 2005). "Tuberculous pericarditis". Circulation. 112 (23): 3608- ...
Bedford, D. Evan (May 1928). "Tuberculous Pericarditis". Proceedings of the Royal Society of Medicine. 21 (7): 1162-1164. doi: ...
Chang SA (November 2017). "Tuberculous and Infectious Pericarditis". Cardiology Clinics. Pericardial Diseases. 35 (4): 615-622 ... Constrictive pericarditis is a rare cause. Masses can grow to press on major blood vessels causing shock. A pneumothorax occurs ... January 2020). "Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review". Journal of the American College ... Imazio M, Gaita F, LeWinter M (October 2015). "Evaluation and Treatment of Pericarditis: A Systematic Review". JAMA. 314 (14): ...
Smedema, J; Katjitae, I; Reuter, H; Doubell, A.F (November 2000). "Ewart's sign in tuberculous pericarditis". South African ...
Barrett, A. M.; Cole, L. (1944). "A Case of Tuberculous Pericarditis". Heart. 6 (4): 185-90. doi:10.1136/hrt.6.4.185. PMC ...
Cinar B, Enc Y, Goksel O, Cimen S, Ketenci B, Teskin O, Kutlu H, Eren E (2006). "Chronic constrictive tuberculous pericarditis ... Related conditions are bacterial pericarditis, pericarditis and pericarditis after a heart attack. The cause of constrictive ... Causes of constrictive pericarditis include: Tuberculosis Incomplete drainage of purulent pericarditis Fungal and parasitic ... "Restrictive pericarditis". eMedicine. MedScape. Retrieved 21 September 2015. "Imaging in Constrictive pericarditis". eMedicine ...
Pneumococcus or tuberculous pericarditis are the most common bacterial forms. Anaerobic bacteria can also be a rare cause. ... pericarditis is divided into "acute" and "chronic" forms. Acute pericarditis is more common than chronic pericarditis, and can ... Chronic pericarditis however is less common, a form of which is constrictive pericarditis. The following is the clinical ... It carries a risk of death between 5 and 10%. About 30% of people with viral pericarditis or pericarditis of an unknown cause ...
Another name for cirrhosis of the liver associated with childhood tuberculous pericarditis is sometimes referred to as " ...
... pericarditis, tuberculous MeSH C01.252.410.040.552.846.570 - tuberculosis, central nervous system MeSH C01.252.410.040.552.846. ... tuberculous MeSH C01.539.739.969 - whooping cough MeSH C01.539.757.720 - septicemia MeSH C01.539.757.720.100 - bacteremia MeSH ... tuberculous MeSH C01.539.830.305.330 - empyema, subdural MeSH C01.539.830.694 - otitis media, suppurative MeSH C01.539.830.840 ... tuberculous MeSH C01.252.410.040.552.846.493 - tuberculoma MeSH C01.252.410.040.552.846.493.400 - tuberculoma, intracranial ...
... pericarditis, constrictive MeSH C14.280.720.801 - pericarditis, tuberculous MeSH C14.280.945.900 - ventricular dysfunction, ...
1952 Jan-Feb;20(1): 37-46, PMID 14937396 Mechanism of healing of tuberculous cavity, Manteuffel-Szoege L., Gruźlica. 1951, Mar- ... Warszawa), 1955 Dec 19;10(51):1653-5 (pl), PMID 13310309 Surgical treatment of constrictive pericarditis; Ten case reports, ...
The incidence of tuberculous peritonitis is particularly high in patients with cirrhosis of the liver. There are broadly two ... The dose for pericarditis is prednisolone 60 mg daily tapered off over four to eight weeks.[medical citation needed] Steroids ... There is good evidence from randomised-controlled trials to say that in tuberculous lymphadenitis and in TB of the spine, the ... All first-line anti-tuberculous drug names have semi-standardized three-letter and single-letter abbreviations:[citation needed ...
Codeine-based cough syrups to control the cough There may be a role for the use of corticosteroids (for tuberculous pleurisy), ... Other conditions that can produce similar symptoms include pericarditis, heart attack, cholecystitis, pulmonary embolism, and ... pericarditis) Inflammatory bowel disease Lung cancer and lymphoma Other lung diseases like cystic fibrosis, sarcoidosis, ...
In patients with tuberculous meningitis, the addition of aspirin reduced the risk of new cerebral infarction [RR = 0.52 (0.29- ... Specific inflammatory conditions which aspirin is used to treat include Kawasaki disease, pericarditis, and rheumatic fever. ... pericarditis, and Kawasaki disease. Lower doses of aspirin have also been shown to reduce the risk of death from a heart attack ...

No FAQ available that match "pericarditis tuberculous"

No images available that match "pericarditis tuberculous"